James Dundas Lane
Professor Emeritus in Psychiatry and Behavioral Sciences
1.) Laboratory studies of caffeine effects on cardiovascular and neuroendocrine measures of stress reactivity. -- My research has repeatedly shown that caffeine can augment or potentiate cardiovascular and neuroendocrine stress responses in the laboratory. Recently we have investigated how caffeine affects other patterns of simple and complex cardiovascular responses.
2.) Ambulatory studies of the cardiovascular and neuroendocrine effects of caffeine. -- This research will establish whether laboratory effects generalize to the real world. Thus far I have shown that caffeine administration can potentiate epinephrine excretion during normal workday activities, suggesting that caffeine may have intensified the neuroendocrine effects of work-related stress, and that caffeine administration can raise ambulatory blood pressure and heart rate during the workday.
3.) Studies of brief caffeine deprivation. -- I am investigating how brief periods of caffeine deprivation may affect mood, physical symptoms, and cognitive or psychomotor performance. Subjects are tested a midday following mornings of caffeine intake or caffeine abstinence to simulate what happens when habitual coffee drinkers are deprived of morning coffee. Studies to date have consistently demonstrated increases in negative mood and decreases in alertness along with headache, even in this relatively short period of time. Thus far no effects on performance have been observed, but I am investigating a variety of tasks and task factor to determine the conditions necessary to observe experimentally the cognitive deficits that subjects report.
4.) Interactions between coffee drinking and cigarette smoking. -- These studies explore whether caffeine or coffee increases the health risks associated with smoking or serves to maintain smoking behavior in ways that make quitting more difficult. Thus far I have tested: the separate and combined effects of caffeine and smoking on cardiovascular and neuroendocrine measures of sympathetic activity and mood; the effects of single and combined caffeine and smoking abstinence on mood, symptoms, and cognitive performance; whether changes in daily caffeine dose alter smoking behavior; and whether coffee drinking could stimulate smoking by serving as a learned cue for smoking behavior.
A second research area concerns the health effects of meditation training. We are currently conducting a controlled clinical trial testing the effects of meditation as a behavioral adjunct for reduction of blood pressure. The study involves both laboratory and ambulatory measurements of blood pressure outcome, and investigates stress-reduction as a mechanism for clinical treatment effects.
I have conducted preliminary research in several other areas. More extensive programs in these areas are currently under development.
1.) Behavioral factors in glycemic control in Type II diabetes. -- These include studies of the role of stress reactivity in glycemic control in patients with diabetes; the potential benefits of stress management education to improve glycemic control; the detrimental effects of caffeine and nicotine consumption on glycemic control; and the relationships between personality traits, self-care behaviors, and glycemic control.
2.) The role of oxidative stress in the harmful effects of cigarette smoking. -- I have demonstrated that oxidative stress decreases soon after smokers quit, and I am pursuing the study of the role of antioxidants in preventing the damage caused by smoking, including the use of antioxidant nutritional supplements to reduce oxidative stress.
3.) The effects of binaural beat auditory stimulation. -- Preliminary evidence suggests that listening to binaural beats, the wavering sound produced when two slightly different sound frequencies are presented stereophonically, can enhance or impair performance and mood in a vigilance task. Other evidence suggests that this stimulation can differentially entrain EEG spectral power, perhaps providing a means to control cognitive and emotional functioning. Studies will investigate the phenomenon, its physiological foundations, and it practical applications.
Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity awarded by National Institutes of Health (Co Investigator). 2011 to 2015
Discrimination & Short & Long-Term Risks for Depression awarded by National Institutes of Health (Programmer). 2005 to 2011
Stress and Behavior in Health and Disease awarded by National Institutes of Health (Mentor). 1989 to 2011
Caffeine and Glucose Regulation awarded by National Institutes of Health (Principal Investigator). 2004 to 2010
Hostility, Race, and Glucose Metabolism awarded by National Institutes of Health (Co Investigator). 2003 to 2009
Meditation for High Blood Pressure awarded by National Institutes of Health (Principal Investigator). 2001 to 2006
Differential Response to CBT in Type 1 & Type 2 Diabetes awarded by National Institutes of Health (Senior Investigator). 2000 to 2005
Gender, Coping, and the Arthritis Pain Experience awarded by National Institutes of Health (Co Investigator). 1999 to 2004
Caffeine Effects On Stress Reactivity awarded by National Institutes of Health (Principal Investigator). 1995 to 2003
Surveillance And Analysis Of The Unc Alumni Heart Study awarded by National Institutes of Health (Co-Principal Investigator). 1996 to 1999
Turow, G., and J. D. Lane. “Binaural beat stimulation: Altering vigilance and mood states.” Music, Science, and the Rhythmic Brain: Cultural and Clinical Implications, 2012, pp. 122–36. Scopus, doi:10.4324/9780203805299. Full Text
Shapiro, Davod, et al. “Caffeine, cardiovascular reactivity, and cardiovascular disease..” Stress, Reactivity, and Cardiovascular Disease: Status and Prospects, edited by K. A. Matthews et al., John Wiley and Sons, 1986.
Williams, V. P., et al. “Video-Based Coping Skills to Reduce Health Risk and Improve Psychological and Physical Well-Being in Alzheimer's Disease Family Caregivers (vol 72, pg 897, 2010).” Psychosomatic Medicine, vol. 78, no. 7, LIPPINCOTT WILLIAMS & WILKINS, Sept. 2016, pp. 886–886.
Merwin, Rhonda M., et al. “Momentary Predictors of Insulin Restriction Among Adults With Type 1 Diabetes and Eating Disorder Symptomatology..” Diabetes Care, vol. 38, no. 11, Nov. 2015, pp. 2025–32. Pubmed, doi:10.2337/dc15-0753. Full Text
Lane, James D., et al. “Pilot Study of Caffeine Abstinence for Control of Chronic Glucose in Type 2 Diabetes..” J Caffeine Res, vol. 2, no. 1, May 2012, pp. 45–47. Pubmed, doi:10.1089/jcr.2012.0003. Full Text
Surwit, Richard S., et al. “EPINEPHRINE, TRUNK FAT AND FASTING GLUCOSE.” Annals of Behavioral Medicine, vol. 43, SPRINGER, Apr. 2012, pp. S155–S155.
Williams, Virginia P., et al. “Video-based coping skills to reduce health risk and improve psychological and physical well-being in Alzheimer's disease family caregivers..” Psychosom Med, vol. 72, no. 9, Nov. 2010, pp. 897–904. Pubmed, doi:10.1097/PSY.0b013e3181fc2d09. Full Text
Surwit, Richard S., et al. “Plasma epinephrine predicts fasting glucose in centrally obese African-American women..” Obesity (Silver Spring), vol. 18, no. 9, Sept. 2010, pp. 1683–87. Pubmed, doi:10.1038/oby.2010.43. Full Text
Surwit, Richard S., et al. “Hostility and minimal model of glucose kinetics in African American women..” Psychosom Med, vol. 71, no. 6, July 2009, pp. 646–51. Pubmed, doi:10.1097/PSY.0b013e3181acee4c. Full Text
Georgiades, Anastasia, et al. “Hostility and fasting glucose in African American women..” Psychosom Med, vol. 71, no. 6, July 2009, pp. 642–45. Pubmed, doi:10.1097/PSY.0b013e3181acee3a. Full Text
Lane, James D., et al. “Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes..” Diabetes Care, vol. 31, no. 2, Feb. 2008, pp. 221–22. Pubmed, doi:10.2337/dc07-1112. Full Text
Williams, Redford B., et al. “Childhood socioeconomic status and serotonin transporter gene polymorphism enhance cardiovascular reactivity to mental stress..” Psychosom Med, vol. 70, no. 1, Jan. 2008, pp. 32–39. Pubmed, doi:10.1097/PSY.0b013e31815f66c3. Full Text
Reavis, Zackery W., et al. “EIGHT-MONTH STABILITY OF PLASMA EPINEPHRINE AND CORTISOL IN FASTED ADULTS AT BASELINE AND IN RESPONSE TO A GLUCOSE BOLUS.” Psychosomatic Medicine, vol. 81, no. 4, LIPPINCOTT WILLIAMS & WILKINS, 2019, pp. A41–42.
Georgiades, Anastasia, et al. “EPINEPHRINE, CORTISOL AND NON-ESTERIFIED FATTY ACID LEVELS DURING AN INTRAVENOUS GLUCOSE TOLERANCE TEST ARE ASSOCIATED WITH THE ACUTE INSULIN RESPONSE (AIR), AN EARLY RISK MARKER FOR TYPE 2 DIABETES.” Psychosomatic Medicine, vol. 81, no. 4, LIPPINCOTT WILLIAMS & WILKINS, 2019, pp. A42–A42.
Georgiades, Anastasia, et al. “REDUCED ADRENAL MEDULLARY ACTIVITY MAY BE IMPORTANT FOR THE MAINTENANCE OF NORMAL GLUCOSE REGULATION IN THE OBESE STATE.” Psychosomatic Medicine, vol. 80, no. 3, LIPPINCOTT WILLIAMS & WILKINS, 2018, pp. A65–A65.
Lane, James D., et al. “BLOOD PRESSURE 'NON-DIPPING' STATUS IS ASSOCIATED WITH GREATER OVERNIGHT EPINEPHRINE EXCRETION.” Psychosomatic Medicine, vol. 75, no. 3, LIPPINCOTT WILLIAMS & WILKINS, 2013, pp. A31–A31.
Georgiades, Anastasia, et al. “Plasma Epinephrine Levels Determine Fasting and Stress Induced Glucose Levels in Women With High Central Adiposity.” Obesity, vol. 17, NATURE PUBLISHING GROUP, 2009, pp. S54–S54.